The Food and Drug Administration (FDA) announced last week that it will be “significantly” reducing that use of the controversial diabetes medication Avandia. However, the European Union’s European Medicines Agency has banned the use of the drug in Europe.
DePuy Orthopaedics, a Johnson & Johnson subsidiary, has issued a voluntary recall on two of its hip replacement devices. The recall is for the DePuy ASR XL Acetabular System and the DePuy ASR Hip Resurfacing System. An estimated 93,000 people may be affected by this recall.